FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Denison Pharmaceuticals Adult Cough and Chest Congestion Recall

Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP 400m…

Denison Pharmaceuticals, LLC · Lincoln, RI

Risk level
Class III
Reported by FDA
Nov 13, 2024
Recall ID
D-0033-2025
Check your lot numberHow we source this data

Summary

Denison Pharmaceuticals recalled Adult Cough and Chest Congestion starting Sep 25, 2024. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0033-2025 on Nov 13, 2024. Reason: Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles. Status: Ongoing.

Why it was recalled

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Product description

Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP 400mg), packaged in 4 oz bottles further package in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code # 850015736155

Lot numbers, UPCs & expiration codes

Lot# 0104V, Exp 07/2025; 0106V, Exp 09/2024

Where it was sold

Product was distributed to two accounts that may have distributed the product further to the Retail Level.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0033-2025
Classification
Class III
Status
Ongoing
Recall initiated
Sep 25, 2024
FDA report date
Nov 13, 2024
Quantity
72,648 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Denison Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0033-2025, exactly as published.

Show all FDA fields
City
Lincoln
State
RI
Status
Ongoing
Country
United States
Event ID
95430
Address
1 Powder Hill Rd
Code information
Lot# 0104V, Exp 07/2025; 0106V, Exp 09/2024
Postal code
02865-4407
Report date
Nov 13, 2024
Product type
Drugs
Recall number
D-0033-2025
Classification
Class III
Recalling firm
Denison Pharmaceuticals, LLC
Product quantity
72,648 bottles
Reason for recall
Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP 400mg), packaged in 4 oz bottles further package in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code # 850015736155
Distribution pattern
Product was distributed to two accounts that may have distributed the product further to the Retail Level.
Recall initiation date
Sep 25, 2024
Initial firm notification
Letter
Center classification date
Nov 1, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0033-2025, published Nov 13, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls